In a recent study published in Nature Cell Biology, researchers assessed the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and deoxyribonucleic acid (DNA) ...

A recent study published in the Science Advances Journal demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and viral fusogens cause glial and neuronal fusion.

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer's disease. In a new study ...

Brain fog following COVID-19 infection can cause cognitive deficits such as headaches, fuzzy thinking, confusion, and forgetfulness in affected individuals. The paper in Science Advances, published by ...

The SARS-CoV-2 virus and the illness it causes, COVID-19, have made an indelible mark on our lives. It seems that is also true in more ways than one; new research has shown that when the virus infects ...

The World Health Organization (WHO) today moved to calm the increasingly competitive atmosphere that seems to be developing in the quest to identify the cause of worldwide Severe Acute Respiratory ...

COVID-19 severity remains open to several questions. Researchers at the University of California Los Angeles (UCLA) have revealed how SARS-CoV-2 causes acute inflammation instead of the symptoms of a ...

Researchers present a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. The results open up new perspectives in the fight against this ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...